Dimerix (ASX:DXB) just closed a 2nd licensing deal
Dimerix (ASX:DXB) did it again ASX-listed kidney disease drug developer Dimerix (ASX: DXB) is well positioned to bring its DMX-200…
Read More
James Hardie (ASX:JHX): Things have turned glum and there could be worse to come, but are fears overblown?
James Hardie (ASX:JHX) is one of the companies many would struggle to have sympathy for. It had a tortured history…
Read More
BHP wanted to buy Anglo American, but not even A$75bn could get the deal over the line
Nearly a month since it was made clear BHP wanted to buy Anglo American, it seems the deal is off.…
Read More